Growth Metrics

Rhythm Pharmaceuticals (RYTM) Inventory Average (2023 - 2025)

Historic Inventory Average for Rhythm Pharmaceuticals (RYTM) over the last 3 years, with Q3 2025 value amounting to $20.5 million.

  • Rhythm Pharmaceuticals' Inventory Average rose 5828.73% to $20.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.5 million, marking a year-over-year increase of 5828.73%. This contributed to the annual value of $13.7 million for FY2024, which is 13711.12% up from last year.
  • Per Rhythm Pharmaceuticals' latest filing, its Inventory Average stood at $20.5 million for Q3 2025, which was up 5828.73% from $19.1 million recorded in Q2 2025.
  • Rhythm Pharmaceuticals' Inventory Average's 5-year high stood at $20.5 million during Q3 2025, with a 5-year trough of $4.2 million in Q1 2023.
  • Its 3-year average for Inventory Average is $12.0 million, with a median of $10.3 million in 2024.
  • Within the past 5 years, the most significant YoY rise in Rhythm Pharmaceuticals' Inventory Average was 12215.28% (2025), while the steepest drop was 5828.73% (2025).
  • Over the past 3 years, Rhythm Pharmaceuticals' Inventory Average (Quarter) stood at $8.2 million in 2023, then skyrocketed by 99.17% to $16.3 million in 2024, then rose by 25.56% to $20.5 million in 2025.
  • Its Inventory Average was $20.5 million in Q3 2025, compared to $19.1 million in Q2 2025 and $19.0 million in Q1 2025.